- Home
- RCUS vs CLMT Comparison
RCUS vs CLMT Comparison
Compare RCUS & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | CLMT |
|---|---|---|
| Founded | 2015 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.4B |
| IPO Year | 2018 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RCUS | CLMT |
|---|---|---|
| Price | $24.89 | $53.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $31.90 | $28.65 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.39 |
| EPS | ★ N/A | N/A |
| Revenue | $247,000,000.00 | ★ $4,137,100,000.00 |
| Revenue This Year | N/A | $3.94 |
| Revenue Next Year | $45.62 | $1.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.87 | $17.42 |
| 52 Week High | $31.74 | $59.87 |
Technical Indicators
Market Signals| Indicator | RCUS | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 51.69 |
| Support Level | $22.92 | $39.44 |
| Resistance Level | $26.43 | N/A |
| Average True Range (ATR) | 1.30 | 2.43 |
| MACD | -0.10 | -0.73 |
| Stochastic Oscillator | 24.23 | 21.01 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.